Quarterly Report • Nov 4, 2021
Quarterly Report
Open in ViewerOpens in native device viewer
Quarterly statement as at 30 September 2021
| in EUR million | 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|
| 1.1.– | 1.7.– | +/– | 1.1.– | +/– | 1.7.– | 1.1.– | 31.12. ¹ | |
| 30.6. | 30.9. | previous year |
30.9. | previous year |
30.9. | 30.9. | ||
| Results | ||||||||
| Gross written premium | 14,464.6 | 7,155.0 | +16.4% | 21,619.6 | +12.0% | 6,148.8 | 19,294.9 | |
| Net premium earned | 11,515.3 | 6,118.6 | +13.4% | 17,633.9 | +11.8% | 5,393.6 | 15,771.7 | |
| Net underwriting result ² | 124.3 | (187.0) | (62.8) | (108.9) | (439.2) | |||
| Net investment income | 865.8 | 491.1 | +25.3% | 1,356.9 | +14.5% | 391.9 | 1,185.0 | |
| Operating profit (EBIT) | 956.1 | 324.5 | -18.7% | 1,280.6 | +41.8% | 399.3 | 902.9 | |
| Group net income | 670.6 | 185.4 | -30.2% | 855.9 | +28.2% | 265.5 | 667.8 | |
| Balance sheet | ||||||||
| Policyholders' surplus | 14,859.2 | 15,238.2 | +8.3% | 14,071.0 | ||||
| Equity attributable to shareholders of Hannover Rück SE |
11,050.6 | 11,409.0 | +3.8% | 10,995.0 | ||||
| Non-controlling interests | 831.7 | 851.7 | +0.9% | 844.4 | ||||
| Hybrid capital | 2,976.9 | 2,977.5 | +33.4% | 2,231.6 | ||||
| Investments (excl. Funds withheld by ceding companies) |
52,847.7 | 55,029.9 | +12.3% | 49,001.6 | ||||
| Total assets | 78,099.2 | 81,788.2 | +14.5% | 71,437.5 | ||||
| Share | ||||||||
| Earnings per share (basic and diluted) in EUR |
5.56 | 1.54 | -30.2% | 7.10 | +28.2% | 2.20 | 5.54 | |
| Book value per share in EUR | 91.63 | 94.60 | +3.8% | 89.74 | 91.17 | |||
| Share price at the end of the period in EUR |
141.10 | 151.35 | +16.2% | 132.20 | 130.30 | |||
| Market capitalisation at the end of the period |
17,016.3 | 18,252.4 | +16.2% | 15,942.9 | 15,713.8 | |||
| Ratios | ||||||||
| Combined ratio (property and casualty reinsurance) ² |
96.0% | 101.5% | 97.9% | 99.6% | 101.4% | |||
| Large losses as percentage of net pre mium earned (property and casualty reinsurance) ³ |
4.2% | 17.6% | 8.9% | 11.3% | 10.9% | |||
| Retention | 90.4% | 88.4% | 89.8% | 88.6% | 90.1% | |||
| Return on investment (excl. funds withheld by ceding companies) |
2.7% | 3.3% | 2.9% | 3.0% | 2.8% | |||
| EBIT margin ⁴ | 8.3% | 5.3% | 7.3% | 7.4% | 5.7% | |||
| Return on equity (after tax) | 12.2% | 6.6% | 10.2% | 9.9% | 8.3% |
¹ Restated pursuant to IAS 8
² Including interest on funds withheld and contract deposits
³ Hannover Re Group's net share for natural catastrophes and other major losses in excess of EUR 10 million gross as a percentage of net premium earned
⁴ Operating result (EBIT)/net premium earned
| Quarterly Statement Business development |
2 2 |
|---|---|
| Results of operations, financial positions and net assets | 3 |
| Property and casualty reinsurance | 3 |
| Life and health reinsurance | 4 |
| Investments | 5 |
| Outlook | 8 |
| Outlook for 2021 | 8 |
| Consolidated balance sheet as at 30 September 2021 | 10 |
| Consolidated statement of income as at 30 September 2021 | 12 |
| Consolidated statement of comprehensive income as at 30 September 2021 | 13 |
| Group segment report as at 30 September 2021 | 14 |
| Consolidated cash flow statement as at 30 September 2021 | 18 |
| Other information | 19 |
| Contact information | 20 |
The present document is a quarterly statement pursuant to Section 51a of the Exchange Rules or the Frankfurter Wertpapierbörse.
For further information please see the section "Other information" on page 19 of this document.
Hannover Re can look back on a nine-month result that further underscored the resilience of its business model as a globally diversified and robustly capitalised reinsurer in a volatile market.
After major loss expenditure in property and casualty reinsurance had remained comfortably below expectations in the first half of the year, it came in significantly over budget in the third quarter. Furthermore, additional pandemic-related strains were incurred in life and health reinsurance in the third quarter. The result was also adversely affected by exchange rate losses.
These pressures were opposed by some positive effects. While the underlying property & casualty and life & health reinsurance business showed a stable development in line with expectations, the investments delivered a substantially better profit contribution than anticipated. As an additional factor, positive special effects were recorded in life and health reinsurance.
Gross written premium for the Group increased by 12.0% as at 30 September 2021 to EUR 21.6 billion (previous year: EUR: 19.3 billion). Growth would have reached 14,4 % at constant exchange rates. The retention is roughly on a par with the previous year at 89.8% (90.1%). Net premium earned increased by 11.8% to EUR 17.6 billion (EUR 15.8 billion), equivalent to growth of 13.9 % adjusted for exchange rate effects.
Investment income improved by 14.5% year-on-year to EUR 1,356.9 million (EUR 1,185.0 million). The annualised return on investment thus reached 2.9% and was above the original full-year target of around 2.4%
Other income and expenses declined by 37.4% to EUR 201.0 million (EUR 321.2 million). This was driven primarily by exchange rate losses of EUR 89 million, after gains of EUR 88 million in the previous year's period.
The operating profit (EBIT) for the Hannover Re Group improved by 41.8% to EUR 1,280.6 million (EUR 902.9 million). Group net income in the first nine months of the year grew by 28.2% to EUR 855.9 million (EUR 667.8 million). Earnings per share came in at EUR 7.10 (EUR 5.54).
Hannover Re's shareholders' equity increased to EUR 11.4 billion as at 30 September 2021 (31 December 2020: EUR 11.0 billion). The annualised return on equity amounted to 10.2% (31 December 2020: 8.3%), clearly beating the minimum target of 900 basis points above the risk-free interest rate. The book value per share thus totalled EUR 94.60 (31 December 2020: EUR 91.17).
The capital adequacy ratio at the end of September stood at 239% and was thus comfortably above our internal limit of 180% and our threshold of 200%.
In October Hannover Re also announced that it was joining the United Nations-convened Net-Zero Insurance Alliance. By committing to achieve net zero targets, Hannover Re is taking a major step towards advancing the transition to a climate-friendly economy. Among other things, we have undertaken to achieve net zero emissions in our own business operations by 2030 and in reinsurance business and investments by 2050.
.
The third quarter in property and casualty reinsurance was impacted by large losses that clearly exceeded expectations. As a result, the total major loss budget of EUR 1.1 billion that we had calculated for the full year was already virtually exhausted by the end of September.
On the other hand, no further net strains have been incurred for Covid-19-related losses over the course of the year.
In response to the present challenges, a sustained improvement in prices and conditions can be observed across a broad front in both primary insurance and reinsurance. In this context we continue to make the profitability of the underwriting results our highest priority, also bearing in mind the protracted low interest rate environment and the sharp uptick in inflation in some areas.
The treaty renewals in property and casualty reinsurance as at 1 June and 1 July passed off correspondingly favourably for Hannover Re. It is at this time of the year that parts of the North American portfolio, some natural catastrophe risks and certain reinsurance risks in credit and surety business are renegotiated. The main renewal season also took place for business in Australia and New Zealand. On the whole, further price increases were obtained here; these were more significant for programmes or regions that had suffered losses.
Gross written premium in the Property&Casualty reinsurance business group increased by 14.4% to EUR 15.3 billion (previous year: EUR 13.3 billion). At constant exchange rates growth would have reached 17,7 %. Net premium earned improved by 14.9% to EUR 12.1 billion (EUR 10.5 billion); growth would have amounted to 17.8% adjusted for exchange rate effects.
Particularly significant drivers of the major loss expenditure in the third quarter were the flood damage in Europe and hurricane losses in the United States, although losses caused by civil unrest in South Africa and by other natural perils were also a factor here. Our net burden of large losses as at 30 September came to altogether EUR 1,070.2 million (EUR 1,149.3 million). This was considerably higher than the figure of EUR 849 million that we had budgeted for the first nine months. The largest individual losses for net account were Hurricane Ida at EUR 305.7 million, storm damage associated with the low-pressure system Bernd costing EUR 214.2 million, civil unrest in South Africa in an amount of EUR 93.8 million and flooding in China totalling EUR 34.5 million. We designate events for which we anticipate gross loss payments of more than EUR 10 million as major losses.
The underwriting result for total property and casualty reinsurance including interest on funds withheld and contract deposits stood at EUR 252.6 million (EUR -145.8 million). The combined ratio amounted to 97.9% (101.4%). While large losses took a significant toll on the result, the underlying business developed as planned and the growth booked in an attractive pricing environment continued to surpass our expectations.
The income from assets under own management booked for property and casualty reinsurance grew by 43.4 % to EUR 956.9 million (EUR 667.1 million).
The operating profit (EBIT) for the Property&Casualty reinsurance business group improved by 80.3% to EUR 1,061.2 million (EUR 588.5 million). The net income generated in property and casualty reinsurance surged by 76.8% to EUR 739.2 million (EUR 418.2 million)
| in EUR million | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|
| 1.1.– 30.6. |
1.7.– 30.9. |
+/– previous year |
1.1.– 30.9. |
+/– previous year |
1.7.– 30.9. |
1.1.– 30.9. |
|
| Gross written premium | 10,266.5 | 5,002.8 | +19.9% | 15,269.3 | +14.4% | 4,173.4 | 13,347.6 |
| Net premium earned | 7,846.6 | 4,229.3 | +16.1% | 12,075.9 | +14.9% | 3,643.0 | 10,512.0 |
| Net underwriting result ¹ | 316.8 | (64.1) | 252.6 | -273.3% | 14.9 | (145.8) | |
| Net investment income | 584.4 | 404.9 | +62.2% | 989.3 | +39.7% | 249.6 | 708.3 |
| Operating result (EBIT) | 777.9 | 283.3 | -5.1% | 1,061.2 | +80.3% | 298.5 | 588.5 |
| Group net income | 592.1 | 147.1 | -15.2% | 739.2 | +76.8% | 173.4 | 418.2 |
| Earnings per share in EUR | 4.91 | 1.22 | -15.2% | 6.13 | +76.8% | 1.44 | 3.47 |
| EBIT margin ² | 9.9% | 6.7% | 8.8% | 8.2% | 5.6% | ||
| Combined ratio ¹ | 96.0% | 101.5% | 97.9% | 99.6% | 101.4% | ||
| Retention | 91.3% | 88.4% | 90.4% | 88.0% | 90.3% |
¹ Including interest on funds withheld and contract deposits
² Operating result (EBIT)/net premium earned
The Covid-19 pandemic continued to be a dominant issue in life and health reinsurance during the first nine months of the financial year, especially in the area of mortality covers. The pandemic-related strains incurred by Hannover Re in life and health reinsurance as at the end of September totalled EUR 403.5 million. Of this, the third quarter accounted for EUR 140.1 million.
The bulk of the claims relating to the Covid-19 pandemic in the first nine months were attributable – in an amount of EUR 196.6 million – to the United States, the largest market for mortality covers. South Africa, in particular, similarly saw further high pandemic-related losses in the third quarter. Overall, it remains our assumption that the expenditures will continue to diminish progressively as vaccination programmes make further progress.
As already reported, the losses incurred from the pandemic in the first quarter were offset by positive one-time income from a restructuring measure in US mortality business in an amount of EUR 129.3 million. A positive special effect of EUR 99.0 million was additionally booked in longevity business in the third quarter.
At the same time, we are benefiting from sustained brisk demand globally in financial solutions business, where we offer our clients individual reinsurance solutions designed to improve their solvency, liquidity and capital position. Similarly, we continue to see strong interest worldwide in coverage concepts for longevity risks among customers such as primary insurers and pension funds.
The gross premium volume climbed by 6.8% as at 30 September to EUR 6.4 billion (previous year: EUR 5.9 billion). Adjusted for exchange rate effects, growth stood at 6.9%. Net premium earned increased by 5.7% to EUR 5.6 billion (EUR 5.3 billion). At constant exchange rates the increase would have reached 6.0%.
The income generated for life and health reinsurance from assets under own management declined, in part due to positive one-time income recognised in the previous year, by 47.5% to EUR 184.5 million (EUR 351.7 million). The underwriting result including interest on funds withheld and contract deposits stood at EUR -315.3 million (EUR -293.2 million).
The operating result (EBIT) declined by 30.2% to EUR 220.1 million (EUR 315.5 million). The contribution made
by life and health reinsurance to Group net income fell by 49.5% to EUR 149.7 million (EUR 296.6 million).
| in EUR million | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|
| 1.1.– | 1.7.– | +/– | 1.1.– | +/– | 1.7.– | 1.1.– | |
| 30.6. | 30.9. | previous year |
30.9. | previous year |
30.9. | 30.9. | |
| Gross written premium | 4,198.1 | 2,152.2 | +9.0% | 6,350.3 | +6.8% | 1,975.4 | 5,947.3 |
| Net premium earned | 3,668.5 | 1,889.2 | +7.9% | 5,557.7 | +5.7% | 1,750.5 | 5,259.4 |
| Investment income | 280.7 | 86.0 | -39.3% | 366.6 | -22.8% | 141.7 | 474.6 |
| Operating result (EBIT) | 179.1 | 41.1 | -59.5% | 220.1 | -30.2% | 101.3 | 315.5 |
| Net income after tax | 104.8 | 44.9 | -58.5% | 149.7 | -49.5% | 108.2 | 296.6 |
| Earnings per share in EUR | 0.87 | 0.37 | -58.5% | 1.24 | -49.5% | 0.90 | 2.46 |
| Retention | 88.2% | 88.4% | 88.3% | 89.9% | 89.5% | ||
| EBIT margin ¹ | 4.9% | 2.2% | 4.0% | 5.8% | 6.0% |
¹ Operating result (EBIT)/net premium earned
The performance of our investments in the first nine months of the year was very pleasing. In addition to the ongoing pandemic, however, numerous geopolitical and economic challenges remain. On the key fixed-income markets for our company increases in the interest rate level – which in some instances were very appreciable – were observed in the first quarter for our main currency areas, especially in the longer maturity segments. Despite modest retreats subsequently recorded in some areas, the renewed rise in the interest rate level seen at the end of the third quarter was beneficial both for new investments and our reinvesting activities. Interest rates nevertheless remain very low. The same is true of risk premiums on corporate bonds.
Equity markets surged sharply higher in the first three months of the year, but increasingly tended to move sideways as the second quarter progressed. The price corrections seen by the end of the third quarter were in some instances significant. We are keeping a close eye on inflation, but currently expect the effects to be primarily of a temporary nature – such as supply chain disruptions and pent-up demand. We no longer see any appreciable implications of the pandemic's economic impacts for our investments.
Going forward, sustainability considerations will exert an even greater influence on the selection and composition of our investments. As part of our sustainability strategy, we are actively scaling back the proportion of securities whose issuers are involved in coal production and converting coal into energy. What is more, we are increasingly making sustainable infrastructure investments and investing in impact investment funds, the goal of which is to generate not only a favourable financial return but also measurably positive effects on the environment and society. In accordance with the Paris Agreement on climate change we are actively reducing the carbon intensity of our investments
Our portfolio of assets under own management grew to EUR 55.0 billion as at 30 September (31 December 2020: EUR 49.0 billion). With credit spreads only slightly narrower overall, higher interest rates led to declines in the fair values of our fixed-income securities. These were comfortably offset by positive exchange rate effects, primarily from the US dollar and pound sterling. The inflow of cash from issuance of a bond and the one-time reclassification of holdings from the technical account to investments as part of a restructuring measure in US mortality business also had favourable implications for the portfolio. Driven principally by the rise in interest rates, the unrealised gains in our fixed-income portfolio contracted to EUR 1.7 billion (31 December 2020: EUR 2.6 billion) as at the end of September.
In the first quarter we made the most of market opportunities and disposed of parts of our equity holdings. As far as fixedincome securities are concerned, we have increasingly focused our new investments and reinvestment activities throughout the year to date on instruments that offer higher returns – in due consideration of the risk profiles – relative to government bonds. We expanded our portfolio of inflation-linked bonds in response to requirements from the technical account as part of regular portfolio maintenance. Furthermore, we vigorously increased our exposure to the infrastructure and private equity segments. We significantly boosted our real estate portfolio in Asia, acting on attractive purchase opportunities in Singapore and Japan. In the area of high-yield bonds we shifted our portfolios out of fund structures and into direct investments. The modified duration of our fixed-income portfolio – at 5.7 (5.8) – was marginally reduced in comparison with the end of the previous year
Totalling EUR 1,083.2 million (EUR 919.4 million), it is pleasing to note that the ordinary investment income excluding interest on funds withheld and contract deposits came in comfortably above the level of the previous year's period and even exceeded our expectations. Ordinary income from fixed-income securities and the real estate sector was considerably higher than in the comparable period. Considerably stronger earnings from our portfolio of inflation-linked bonds, which we hold to limit possible inflation risks, were also a factor here. In addition, we generated very appreciable increases in income booked from alternative investment funds. Interest on funds withheld and contract deposits also came in sharply higher at EUR 214.5 million (EUR 164.1 million).
The net balance of gains realised on disposals amounted to EUR 237.6 million (EUR 192.1 million), primarily reflecting regrouping moves as part of portfolio maintenance and restructuring as well as the aforementioned share sales. In the United States we successfully made the most of conditions on the real estate market by selling a large property. We were also able to realise pleasing gains in connection with the realignment of our high-yield holdings noted above. Impairments of altogether EUR 51.8 were recognised; this amount is significantly lower than in the first three quarters of the previous year (EUR 101.6 million), which was clearly affected by the emerging economic impacts of the Covid-19 pandemic. Of this, EUR 16.0 million (EUR 50.3 million) was attributable to alternative investments and EUR 7.1 million (EUR 11.8 million) to real estate funds. Fixed-income securities accounted for EUR 0.2 million (EUR 11.8 million). The depreciation recognised on directly held real estate was stable at EUR 27.9 million (EUR 27.3 million).
We recognise a derivative for the credit risk associated with special life reinsurance treaties (ModCo) under which securities deposits are held by cedants for our account; the performance of this derivative in the period under review gave rise to unrealised losses of EUR 14.9 million (EUR -8.7 million) recognised in income. In economic terms we assume a neutral development for this item over time, and hence the volatility that can occur in specific quarters provides no insight into the actual business development. Altogether, the unrealised losses in our assets recognised at fair value through profit or loss amounted to EUR 48.5 million (gains of EUR 41.4 million). The key driver here was the performance of a derivative relating to the technical account.
The investment income of EUR 1,356.9 million (EUR 1,185.0 million) improved on the level of the comparable period despite negative changes in the fair values of assets recognised at fair value through profit or loss. Income from assets under own management accounted for EUR 1,142.4 million (EUR 1,020.9 million), producing an annualised average return (including effects from derivatives) of 2.9%.
| in EUR million | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|
| 1.1.– 30.6. |
1.7.– 30.9. |
+/– previous |
1.1.– 30.9. |
+/– previous |
1.7.– 30.9. |
1.1.– 30.9. |
|
| Ordinary investment income ¹ | 681.7 | 401.5 | year +28.8% |
1,083.2 | year +17.8% |
311.7 | 919.4 |
| Result from participations in associated com panies |
16.0 | 6.6 | -88.8% | 22.6 | -65.3% | 58.6 | 65.0 |
| Realised gains/losses | 142.0 | 95.6 | +83.0% | 237.6 | +23.7% | 52.2 | 192.1 |
| Appreciation ² | 38.4 | 13.4 | -18.7% | 51.8 | -49.0% | 16.5 | 101.6 |
| Change in fair value of financial instruments ³ | (43.1) | (5.3) | -42.1% | (48.5) | -216.9% | (9.2) | 41.4 |
| Investment expenses | 64.6 | 36.2 | +10.5% | 100.8 | +5.6% | 32.8 | 95.4 |
| Net investment income from assets under own management |
693.7 | 448.7 | +23.2% | 1,142.4 | +11.9% | 364.1 | 1,020.9 |
| Net investment income from funds withheld | 172.2 | 42.4 | +52.5% | 214.5 | +30.8% | 27.8 | 164.1 |
| Total investment income | 865.8 | 491.1 | +25.3% | 1,356.9 | +14.5% | 391.9 | 1,185.0 |
¹ Excluding interest on funds withheld and contract deposits
² Including depreciation/impairments on real estate
³ Portfolio at fair value through profit or loss and trading
The Covid-19 pandemic continues to set the tone on global reinsurance markets in the current financial year. In property and casualty reinsurance, however, it is our assumption that the pandemic-related net reserves established in 2020 are still adequate overall. Following the considerable major losses incurred in the third quarter, the goal of a combined ratio of 96% or better is no longer attainable in this financial year if large losses in the fourth quarter come in around the budgeted level. The successful treaty renewals have to some extent already made themselves felt in improved profitability prospects in the current financial year and will continue to do so in subsequent years.
In life and health reinsurance, the future pandemic-related loss experience will be dependent on the success of ongoing vaccination campaigns and containment efforts around the world as well as the emergence of virus variants. On the whole, it remains our expectation that the strains will continue to diminish progressively as vaccination programmes make further progress.
Following the good performance in the first nine months, we now expect a return on investment of more than 2.4% for the current financial year. The growth in Group gross premium should be at least in the upper single-digit percentages adjusted for exchange rate effects.
Even after the heavy losses of the third quarter, we consider ourselves well placed in relation to our 2021 full-year guidance, which we still expect to achieve. On the Group level our expectation of net income between EUR 1.15 billion and EUR 1.25 billion for the 2021 financial year remains unchanged. Achievement of the earnings target is dependent on major loss expenditure not significantly exceeding the budgeted level for the fourth quarter of EUR 251 million and assumes that there are no Covid-19-related losses substantially above expectations in life and health reinsurance and no unforeseen distortions on capital markets.
The capital adequacy ratio at the end of the year should remain comfortably above our limit of 180% and our threshold of 200%.
Going forward, Hannover Re intends to place even greater emphasis on the continuity of its dividend payments. From the current financial year onwards, the ordinary dividend will at least be on the level of the previous year. This means that a practice already followed at our company over the past ten years has now been enshrined as a policy – one made possible by the resilience of our business model as a globally diversified and robustly capitalised reinsurer. The ordinary dividend will be supplemented by payment of a special dividend provided the capitalisation exceeds the capital required for future growth and the profit target is achieved.
For the 2022 financial year Hannover Re anticipates Group net income of EUR 1.4 billion to EUR 1.5 billion. In addition, we expect a return on investment of at least 2.3% and growth of at least 5% in Group gross premium adjusted for exchange rate effects.
The expectations for 2022 additionally reflect an increase in the net major loss budget to EUR 1.3 billion (EUR 1.1 billion) that is commensurate with the growth in the underlying business.
As usual, all forward-looking statements regarding future targets are based on the premise that there are no unforeseen distortions on capital markets, that major loss expenditure remains within the budgeted level and that the Covid-19 pandemic does not significantly affect the result in life and health reinsurance.
| in EUR thousand | 30.9.2021 | 31.12.2020 ¹ |
|---|---|---|
| Fixed-income securities - held to maturity | 71,782 | 185,577 |
| Fixed-income securities - loans and receivables | 2,377,690 | 2,312,840 |
| Fixed-income securities - available for sale | 43,668,290 | 38,851,723 |
| Fixed-income securities - at fair value through profit or loss | 73,405 | 105,711 |
| Equity securities - available for sale | 293,059 | 378,422 |
| Other financial assets - at fair value through profit or loss | 190,450 | 234,689 |
| Investment property | 1,856,959 | 1,589,238 |
| Real estate funds | 731,556 | 582,296 |
| Investments in associated companies | 383,514 | 361,617 |
| Other invested assets | 3,202,966 | 2,794,016 |
| Short-term investments | 493,024 | 327,426 |
| Cash and cash equivalents | 1,687,226 | 1,278,071 |
| Total investments and cash under own management | 55,029,921 | 49,001,626 |
| Funds withheld | 10,894,478 | 9,659,807 |
| Contract deposits | 408,915 | 298,344 |
| Total investments | 66,333,314 | 58,959,777 |
| Reinsurance recoverables on unpaid claims | 2,543,288 | 1,883,270 |
| Reinsurance recoverables on benefit reserve | 180,588 | 192,135 |
| Prepaid reinsurance premium | 308,846 | 165,916 |
| Reinsurance recoverables on other technical reserves | 1,782 | 1,106 |
| Deferred acquisition costs | 3,580,679 | 3,073,117 |
| Accounts receivable | 7,368,552 | 5,605,803 |
| Goodwill | 83,063 | 80,965 |
| Deferred tax assets | 510,038 | 597,986 |
| Other assets | 859,641 | 859,136 |
| Accrued interest and rent | 18,373 | 18,264 |
| Total assets | 81,788,164 | 71,437,475 |
¹ Restated pursuant to IAS 8
| Liabilities | ||
|---|---|---|
| in EUR thousand | 30.9.2021 | 31.12.2020 ¹ |
| Loss and loss adjustment expense reserve | 39,082,146 | 33,929,230 |
| Benefit reserve | 7,373,009 | 7,217,988 |
| Unearned premium reserve | 7,235,633 | 5,070,009 |
| Other technical provisions | 750,740 | 701,577 |
| Funds withheld | 671,140 | 582,316 |
| Contract deposits | 3,612,995 | 3,255,453 |
| Reinsurance payable | 2,415,394 | 1,777,761 |
| Provisions for pensions | 204,597 | 229,252 |
| Taxes | 168,141 | 132,736 |
| Deferred tax liabilities | 2,752,146 | 2,731,648 |
| Other liabilities | 910,727 | 538,813 |
| Financing liabilities | 4,350,780 | 3,431,276 |
| Total liabilities | 69,527,448 | 59,598,059 |
| Shareholders' equity | ||
| Common shares | 120,597 | 120,597 |
| Nominal value: 120,597 Conditional capital: 24,119 | ||
| Additional paid-in capital | 724,562 | 724,562 |
| Common shares and additional paid-in capital | 845,159 | 845,159 |
| Cumulative other comprehensive income | ||
| Unrealised gains and losses on investments | 1,867,810 | 2,275,936 |
| Cumulative foreign currency translation adjustment | 163,279 | (330,693) |
| Changes from hedging instruments | (8,459) | (8,678) |
| Other changes in cumulative other comprehensive income | (69,511) | (83,792) |
| Total other comprehensive income | 1,953,119 | 1,852,773 |
| Retained earnings | 8,610,709 | 8,297,114 |
| Equity attributable to shareholders of Hannover Rück SE | 11,408,987 | 10,995,046 |
| Non-controlling interests | 851,729 | 844,370 |
| Total shareholders' equity | 12,260,716 | 11,839,416 |
| Total liabilities | 81,788,164 | 71,437,475 |
¹ Restated pursuant to IAS 8
| Gross written premium 7,155,047 21,619,646 |
6,148,779 | 19,294,915 |
|---|---|---|
| Ceded written premium 827,680 2,212,223 |
700,118 | 1,913,861 |
| Change in gross unearned premium (243,350) (1,905,724) |
(140,751) | (1,769,454) |
| Change in ceded unearned premium 34,539 132,155 |
85,661 | 160,055 |
| Net premium earned 6,118,556 17,633,854 |
5,393,571 | 15,771,655 |
| Ordinary investment income 401,511 1,083,212 |
311,748 | 919,409 |
| Profit / loss from investments in associated compa nies 6,565 22,584 |
58,580 | 65,011 |
| Realised gains and losses on investments 95,622 237,643 |
52,248 | 192,073 |
| Change in fair value of financial instruments (5,329) (48,470) |
(9,199) | 41,449 |
| Total depreciation, impairments and appreciation of investments 13,385 51,757 |
16,471 | 101,572 |
| Other investment expenses 36,245 100,823 |
32,787 | 95,446 |
| Net income from investments under own man agement 448,739 1,142,389 |
364,119 | 1,020,924 |
| Income / expense on funds withheld and contract deposits 42,359 214,510 |
27,782 | 164,060 |
| Net investment income 491,098 1,356,899 |
391,901 | 1,184,984 |
| Other technical income – 112 |
– | – |
| Total revenues 6,609,654 18,990,865 |
5,785,472 | 16,956,639 |
| Claims and claims expenses 4,988,467 13,619,006 |
4,190,882 | 12,389,179 |
| Change in benefit reserves (144,949) (258,450) |
(23,117) | (168,599) |
| Commission and brokerage, change in deferred ac quisition costs 1,378,443 4,164,024 |
1,256,928 | 3,803,522 |
| Other acquisition costs 865 3,108 |
962 | 3,338 |
| Administrative expenses 125,121 383,556 |
104,575 | 347,519 |
| Total technical expenses 6,347,947 17,911,244 |
5,530,230 | 16,374,959 |
| Other income 155,115 551,296 |
213,648 | 613,628 |
| Other expenses 92,289 350,277 |
69,548 | 292,457 |
| Other income and expenses 62,826 201,019 |
144,100 | 321,171 |
| Operating profit / loss (EBIT) 324,533 1,280,640 |
399,342 | 902,851 |
| Financing costs 21,307 61,432 |
24,449 | 71,553 |
| Net income before taxes 303,226 1,219,208 |
374,893 | 831,298 |
| Taxes 106,053 318,198 |
90,327 | 141,791 |
| Net income 197,173 901,010 |
284,566 | 689,507 |
| thereof | ||
| Non-controlling interest in profit and loss 11,806 45,091 |
19,106 | 21,695 |
| Group net income 185,367 855,919 |
265,460 | 667,812 |
| Earnings per share (in EUR) | ||
| Basic earnings per share 1.54 7.10 |
2.20 | 5.54 |
| Diluted earnings per share 1.54 7.10 |
2.20 | 5.54 |
| in EUR thousand | 1.7. - 30.9.2021 |
1.1. - 30.9.2021 |
1.7. - 30.9.2020 |
1.1. - 30.9.2020 |
|---|---|---|---|---|
| Net income | 197,173 | 901,010 | 284,566 | 689,507 |
| Not reclassifiable to the consolidated statement of income | ||||
| Actuarial gains and losses | ||||
| Gains (losses) recognised directly in equity | 4,852 | 23,367 | (12,166) | (7,782) |
| Tax income (expense) | (1,579) | (7,620) | 3,971 | 2,553 |
| 3,273 | 15,747 | (8,195) | (5,229) | |
| Changes from the measurement of associated companies | ||||
| Gains (losses) recognised directly in equity | 32 | 166 | (61) | (39) |
| 32 | 166 | (61) | (39) | |
| Income and expense recognised directly in equity that cannot be re classified |
||||
| Gains (losses) recognised directly in equity | 4,884 | 23,533 | (12,227) | (7,821) |
| Tax income (expense) | (1,579) | (7,620) | 3,971 | 2,553 |
| 3,305 | 15,913 | (8,256) | (5,268) | |
| Reclassifiable to the consolidated statement of income | ||||
| Unrealised gains and losses on investments | ||||
| Gains (losses) recognised directly in equity | 34,973 | (383,499) | 319,860 | 1,048,515 |
| Transferred to the consolidated statement of income | (93,843) | (222,661) | (38,544) | (104,596) |
| Tax income (expense) | 44,775 | 198,178 | (69,875) | (196,096) |
| (14,095) | (407,982) | 211,441 | 747,823 | |
| Currency translation | ||||
| Gains (losses) recognised directly in equity | 211,486 | 566,597 | (350,957) | (480,423) |
| Tax income (expense) | (19,744) | (65,582) | 31,942 | 51,955 |
| 191,742 | 501,015 | (319,015) | (428,468) | |
| Changes from the measurement of associated companies | ||||
| Gains (losses) recognised directly in equity | (1,829) | (1,884) | (2,151) | (2,117) |
| (1,829) | (1,884) | (2,151) | (2,117) | |
| Changes from hedging instruments | ||||
| Gains (losses) recognised directly in equity | 2,889 | 491 | (3,620) | (7,787) |
| Tax income (expense) | (640) | (252) | 948 | 2,879 |
| 2,249 | 239 | (2,672) | (4,908) | |
| Reclassifiable income and expense recognised directly in equity | ||||
| Gains (losses) recognised directly in equity | 247,519 | 181,706 | (36,868) | 558,188 |
| Transferred to the consolidated statement of income | (93,844) | (222,661) | (38,544) | (104,596) |
| Tax income (expense) | 24,391 | 132,344 | (36,985) | (141,262) |
| 178,067 | 91,388 | (112,397) | 312,330 | |
| Total income and expense recognised directly in equity | ||||
| Gains (losses) recognised directly in equity | 252,403 | 205,238 | (49,095) | 550,367 |
| Transferred to the consolidated statement of income | (93,844) | (222,661) | (38,544) | (104,596) |
| Tax income (expense) | 22,812 | 124,724 | (33,014) | (138,709) |
| 181,372 | 107,301 | (120,653) | 307,062 | |
| Total recognised income and expense | 378,545 | 1,008,311 | 163,913 | 996,569 |
| thereof | ||||
| Attributable to non-controlling interests | 20,052 | 52,046 | 28,898 | 38,605 |
| Attributable to shareholders of Hannover Rück SE | 358,493 | 956,265 | 135,015 | 957,964 |
| Segmentation of assets | Property and casualty reinsurance | ||||
|---|---|---|---|---|---|
| in EUR thousand | 30.9.2021 | 31.12.2020 ¹ | |||
| Assets | |||||
| Fixed-income securities - held to maturity | 64,641 | 139,867 | |||
| Fixed-income securities - loans and receivables | 1,907,425 | 1,998,611 | |||
| Fixed-income securities - available for sale | 33,352,259 | 29,422,685 | |||
| Equity securities - available for sale | 293,059 | 378,422 | |||
| Financial assets at fair value through profit or loss | 76,806 | 110,304 | |||
| Other invested assets | 5,253,599 | 4,384,139 | |||
| Short-term investments | 316,222 | 244,474 | |||
| Cash | 1,254,464 | 901,989 | |||
| Total investments and cash under own management | 42,518,475 | 37,580,491 | |||
| Funds withheld | 3,526,979 | 2,569,420 | |||
| Contract deposits | 5,943 | 5,404 | |||
| Total investments | 46,051,397 | 40,155,315 | |||
| Reinsurance recoverables on unpaid claims | 2,392,769 | 1,730,507 | |||
| Reinsurance recoverables on benefit reserve | – | – | |||
| Prepaid reinsurance premium | 308,732 | 165,834 | |||
| Reinsurance recoverables on other reserves | 555 | 562 | |||
| Deferred acquisition costs | 1,700,724 | 1,169,521 | |||
| Accounts receivable | 5,823,361 | 4,155,372 | |||
| Other assets in the segment | 3,178,961 | 2,788,243 | |||
| Total assets | 59,456,499 | 50,165,354 |
| in EUR thousand | ||
|---|---|---|
| Liabilities | ||
| Loss and loss adjustment expense reserve | 33,668,219 | 29,194,354 |
| Benefit reserve | – | – |
| Unearned premium reserve | 6,808,309 | 4,709,229 |
| Provisions for contingent commissions | 440,695 | 395,296 |
| Funds withheld | 413,578 | 342,420 |
| Contract deposits | 82,270 | 80,369 |
| Reinsurance payable | 1,747,768 | 1,157,650 |
| Financing liabilities | 596,192 | 420,348 |
| Other liabilities in the segment | 2,696,921 | 2,478,161 |
| Total liabilities | 46,453,952 | 38,777,827 |
¹ Restated pursuant to IAS 8
| Life and health reinsurance | Consolidation | Total | |||||
|---|---|---|---|---|---|---|---|
| 30.9.2021 | 31.12.2020 ¹ | 30.9.2021 | 31.12.2020 ¹ | 30.9.2021 | 31.12.2020 ¹ | ||
| 7,141 | 45,710 | – | – | 71,782 | 185,577 | ||
| 454,543 | 299,180 | 15,722 | 15,049 | 2,377,690 | 2,312,840 | ||
| 10,296,800 | 9,429,038 | 19,231 | – | 43,668,290 | 38,851,723 | ||
| – | – | – | – | 293,059 | 378,422 | ||
| 187,049 | 230,096 | – | – | 263,855 | 340,400 | ||
| 917,732 | 920,960 | 3,664 | 22,068 | 6,174,995 | 5,327,167 | ||
| 176,611 | 82,221 | 191 | 731 | 493,024 | 327,426 | ||
| 428,319 | 371,972 | 4,443 | 4,110 | 1,687,226 | 1,278,071 | ||
| 12,468,195 | 11,379,177 | 43,251 | 41,958 | 55,029,921 | 49,001,626 | ||
| 7,367,499 | 7,090,387 | – | – | 10,894,478 | 9,659,807 | ||
| 402,972 | 292,940 | – | – | 408,915 | 298,344 | ||
| 20,238,666 | 18,762,504 | 43,251 | 41,958 | 66,333,314 | 58,959,777 | ||
| 150,519 | 152,763 | – | – | 2,543,288 | 1,883,270 | ||
| 180,588 | 192,135 | – | – | 180,588 | 192,135 | ||
| 199 | 82 | (85) | – | 308,846 | 165,916 | ||
| 1,227 | 544 | – | – | 1,782 | 1,106 | ||
| 1,879,955 | 1,903,596 | – | – | 3,580,679 | 3,073,117 | ||
| 1,545,191 | 1,450,628 | – | (197) | 7,368,552 | 5,605,803 | ||
| 540,806 | 470,282 | (2,248,652) | (1,702,174) | 1,471,115 | 1,556,351 | ||
| 24,537,151 | 22,932,534 | (2,205,486) | (1,660,413) | 81,788,164 | 71,437,475 |
| 5,413,927 | 4,734,876 | – | – | 39,082,146 | 33,929,230 |
|---|---|---|---|---|---|
| 7,373,009 | 7,217,988 | – | – | 7,373,009 | 7,217,988 |
| 427,324 | 360,780 | – | – | 7,235,633 | 5,070,009 |
| 310,045 | 306,281 | – | – | 750,740 | 701,577 |
| 257,562 | 239,896 | – | – | 671,140 | 582,316 |
| 3,530,725 | 3,175,084 | – | – | 3,612,995 | 3,255,453 |
| 667,966 | 620,111 | (340) | – | 2,415,394 | 1,777,761 |
| 32,217 | 35,010 | 3,722,371 | 2,975,918 | 4,350,780 | 3,431,276 |
| 3,586,860 | 2,863,934 | (2,248,170) | (1,709,646) | 4,035,611 | 3,632,449 |
| 21,599,635 | 19,553,960 | 1,473,861 | 1,266,272 | 69,527,448 | 59,598,059 |
| Segment statement of income | Property and casualty reinsurance | |
|---|---|---|
| in EUR thousand | 1.1. - 30.9.2021 | 1.1. - 30.9.2020 |
| Gross written premium | 15,269,339 | 13,347,606 |
| Net premium earned | 12,075,930 | 10,512,041 |
| Net investment income | 989,295 | 708,252 |
| thereof | ||
| Change in fair value of financial instruments | 4,089 | 1,095 |
| Total depreciation, impairments and appreciation of investments | 51,734 | 99,761 |
| Income / expense on funds withheld and contract deposits | 32,390 | 41,111 |
| Claims and claims expenses | 8,436,706 | 7,658,185 |
| Change in benefit reserve | – | – |
| Commission and brokerage, change in deferred acquisition costs and other technical in come / expenses |
3,233,639 | 2,881,802 |
| Administrative expenses | 185,354 | 158,947 |
| Other income and expenses | (148,360) | 67,161 |
| Operating profit / loss (EBIT) | 1,061,166 | 588,520 |
| Financing costs | 1,545 | 1,576 |
| Net income before taxes | 1,059,621 | 586,944 |
| Taxes | 276,043 | 148,079 |
| Net income | 783,578 | 438,865 |
| thereof | ||
| Non-controlling interest in profit or loss | 44,342 | 20,687 |
| Group net income | 739,236 | 418,178 |
| Life and health reinsurance | Consolidation | Total | |||
|---|---|---|---|---|---|
| 1.1. - 30.9.2021 | 1.1. - 30.9.2020 | 1.1. - 30.9.2021 | 1.1. - 30.9.2020 | 1.1. - 30.9.2021 | 1.1. - 30.9.2020 |
| 6,350,307 | 5,947,309 | – | – | 21,619,646 | 19,294,915 |
| 5,557,677 | 5,259,442 | 247 | 172 | 17,633,854 | 15,771,655 |
| 366,635 | 474,614 | 969 | 2,118 | 1,356,899 | 1,184,984 |
| (52,559) | 40,354 | – | – | (48,470) | 41,449 |
| 23 | 1,811 | – | – | 51,757 | 101,572 |
| 182,120 | 122,949 | – | – | 214,510 | 164,060 |
| 5,182,300 | 4,730,994 | – | – | 13,619,006 | 12,389,179 |
| (258,450) | (168,599) | – | – | (258,450) | (168,599) |
| 933,381 | 925,058 | – | – | 4,167,020 | 3,806,860 |
| 197,855 | 188,178 | 347 | 394 | 383,556 | 347,519 |
| 350,890 | 257,031 | (1,511) | (3,021) | 201,019 | 321,171 |
| 220,116 | 315,456 | (642) | (1,125) | 1,280,640 | 902,851 |
| 1,137 | 1,097 | 58,750 | 68,880 | 61,432 | 71,553 |
| 218,979 | 314,359 | (59,392) | (70,005) | 1,219,208 | 831,298 |
| 68,531 | 16,765 | (26,376) | (23,053) | 318,198 | 141,791 |
| 150,448 | 297,594 | (33,016) | (46,952) | 901,010 | 689,507 |
| 749 | 1,008 | – | – | 45,091 | 21,695 |
| 149,699 | 296,586 | (33,016) | (46,952) | 855,919 | 667,812 |
| in EUR thousand | 1.1. - 30.9.2021 | 1.1. - 30.9.2020 |
|---|---|---|
| I. Cash flow from operating activities | ||
| Net income | 901,010 | 689,507 |
| Appreciation / depreciation | 87,597 | 116,437 |
| Realised gains and losses on investments | (237,643) | (192,073) |
| Change in fair value of financial instruments (through profit or loss) | 48,470 | (41,449) |
| Amortisation | 15,856 | 67,312 |
| Changes in funds withheld | (763,800) | (780,265) |
| Net changes in contract deposits | 125,512 | (99,130) |
| Changes in prepaid reinsurance premium | 1,773,637 | 1,609,399 |
| Change in tax assets / provisions for taxes | 277,048 | (73,016) |
| Change in benefit reserve | (140,463) | (318,596) |
| Change in claims reserves | 3,289,123 | 2,414,399 |
| Change in deferred acquisition costs | (408,867) | (204,436) |
| Change in other technical provisions | 25,924 | 60,746 |
| Change in accounts receivable / payable | (1,006,611) | (526,582) |
| Change in other assets and liabilities | 206,041 | (132,616) |
| Cash flow from operating activities | 4,192,834 | 2,589,637 |
| II. Cash flow from investing activities | (4,147,411) | (1,555,183) |
| III. Cash flow from financing activities | 300,578 | (725,819) |
| IV. Exchange rate differences on cash | 63,154 | (55,117) |
| Cash and cash equivalents at the beginning of the period | 1,278,071 | 1,090,852 |
| Change in cash and cash equivalents (I. + II. + III. + IV.) | 409,155 | 253,518 |
| Cash and cash equivalents at the end of the period | 1,687,226 | 1,344,370 |
| Supplementary information on the cash flow statement ¹ | ||
| Income taxes paid (on balance) | (53,670) | (202,013) |
| Dividend receipts ² | 217,721 | 101,217 |
| Interest received | 1,198,427 | 1,160,044 |
| Interest paid | (315,083) | (225,304) |
¹ The income taxes paid, dividend receipts as well as interest received and paid are included entirely in the cash flow from operating activities.
² Including dividend-like profit participations from investment funds
The present document is a quarterly statement pursuant to Section 51a of the Exchange Rules for the Frankfurter Wertpapierbörse (BörsO FWB). It was drawn up according to the International Financial Reporting Standards (IFRS) that are to be applied within the European Union, but does not constitute an interim financial report as defined by IAS 34 "Interim Financial Reporting" or a financial statement as defined by IAS 1 "Presentation of Financial Statements". In view of the Covid-19 pandemic, estimates are subject to a higher degree of uncertainty and greater use was therefore made of scenario calculations.
The accounting policies are essentially the same as those applied in the consolidated financial statement as at 31 December 2020. In the 2021 financial year a number of amendments to existing standards and interpretations were issued with no significant implications for the consolidated financial statement:
Hannover Re is exercising the temporary exemption from applying IFRS 9 "Financial Instruments" that is available to companies whose activities are predominantly connected with insurance.
Karl Steinle Tel. + 49 511 5604-1500 Fax + 49 511 5604-1648 [email protected]
Oliver Süß Tel. + 49 511 5604-1502 Fax + 49 511 5604-1648 [email protected]
Axel Bock Tel. + 49 511 5604-1736 Fax + 49 511 5604-1648 [email protected]
Hannover Rück SE Karl-Wiechert-Allee 50 30625 Hannover, Germany Tel. + 49 511 5604-0 Fax + 49 511 5604-1188
www.hannover-re.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.